Results 71 to 80 of about 1,444,735 (298)

The translatics of translation

open access: yesJournal of Modern Languages, 2017
The project on which this paper is based offers Translatics as a theory of translation which is designed and developed as an alternative that challenges the mainstream views currently held within translation studies. To familiarize the readers with Translatics, an attempt will be made to provide and describe its foundational key concepts and features ...
openaire   +8 more sources

Multi‐omic characterization of consensus molecular subtype 1 (CMS1) colorectal cancer with dampened immune response improves precision medicine

open access: yesMolecular Oncology, EarlyView.
This study highlights the importance of multi‐omic analyses in characterizing colorectal cancers. Indeed, our analysis revealed a rare CMS1 exhibiting dampened immune activation, including reduced PD‐1 expression, moderate CD8+ T‐cell infiltration, and suppressed JAK/STAT pathway.
Livia Concetti   +10 more
wiley   +1 more source

ChatGPT translation vs. human translation: an examination of a literary text

open access: yesCogent Social Sciences
This study evaluates the proficiency of ChatGPT-based translation compared to Human Translation (HT) using an Arabic literary work. It also examines potential translation gaps in ChatGPT and explores its potential to replace human translators.
Rafat Al Rousan   +2 more
doaj   +1 more source

Rhetoric, Translation, and the Rhetoric of Translation

open access: yesPoroi, 2017
Uvodnik posebnom izdanju časopisa POROI posvećenog retorici, prevođenju i retorici prevođenja. Radovi objavljeni u ovom izdanju dio su projekta Translation and the Making of World Literature.
Valentino, R. S.   +3 more
openaire   +5 more sources

Targeting the AKT/mTOR pathway attenuates the metastatic potential of colorectal carcinoma circulating tumor cells in a murine xenotransplantation model

open access: yesMolecular Oncology, EarlyView.
Dual targeting of AKT and mTOR using MK2206 and RAD001 reduces tumor burden in an intracardiac colon cancer circulating tumor cell xenotransplantation model. Analysis of AKT isoform‐specific knockdowns in CTC‐MCC‐41 reveals differentially regulated proteins and phospho‐proteins by liquid chromatography coupled mass spectrometry. Circulating tumor cells
Daniel J. Smit   +19 more
wiley   +1 more source

Translation, Translation, Translation [PDF]

open access: yesCirculation Research, 2018
Heusch, Gerd   +2 more
openaire   +3 more sources

Early metastasis is characterized by Gr1+ cell dysregulation and is inhibited by immunomodulatory nanoparticles

open access: yesMolecular Oncology, EarlyView.
Breast cancer metastasis is associated with myeloid cell dysregulation and the lung‐specific accumulation of tumor‐supportive Gr1+ cells. Gr1+ cells support metastasis, in part, through a CHI3L1‐mediated mechanism, which can be targeted and inhibited with cargo‐free, polymeric nanoparticles.
Jeffrey A. Ma   +9 more
wiley   +1 more source

MicroRNA 196a contributes to the aggressiveness of esophageal adenocarcinoma through the MYC/TERT/NFκB axis

open access: yesMolecular Oncology, EarlyView.
mir‐196a promotes Esophagus Adenocarcinoma aggressiveness. On one hand, mir‐196a targets the valosin‐containing protein (VCP) mRNA, causing the accumulation of c‐MYC protein that leads to high amounts of TERT. On the other hand, mir‐196a targets the inhibitor of NFκB (NFKBIA).
Jesús García‐Castillo   +8 more
wiley   +1 more source

Intrinsic managing and the English-Arabic translation of fictional registers

open access: yesCogent Arts & Humanities
The translation process involves several changes made to the source text. Some of these changes, referred to as intrinsic managing , are necessary to overcome linguistic differences and create a cohesive, coherent, and natural text without altering the ...
Hadeel Saed   +3 more
doaj   +1 more source

Circulating tumor DNA monitoring and blood tumor mutational burden in patients with metastatic solid tumors treated with atezolizumab

open access: yesMolecular Oncology, EarlyView.
In patients treated with atezolizumab as a part of the MyPathway (NCT02091141) trial, pre‐treatment ctDNA tumor fraction at high levels was associated with poor outcomes (radiographic response, progression‐free survival, and overall survival) but better sensitivity for blood tumor mutational burden (bTMB).
Charles Swanton   +17 more
wiley   +1 more source

Home - About - Disclaimer - Privacy